325 IntOGen-mutations is a discovery tool for cancer researchers to find driver mutations in genes and pathways.
http://www.nature.com/nmeth/journal/v10/n11/abs/nmeth.2642.html
324 A new cloning and expression system yields and validates TCRs from blood lymphocytes of patients with cancer within 10 days.
http://www.nature.com/nm/journal/v19/n11/abs/nm.3358.html
323 Coordinate activation of Shh and PI3K signaling in PTEN-deficient glioblastoma: new therapeutic opportunities.
http://www.nature.com/nm/journal/v19/n11/abs/nm.3328.html
322 The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex.
http://www.nature.com/ng/journal/v45/n11/abs/ng.2771.html
321 Monoallelic loss of tumor suppressor GRIM-19 promotes tumorigenesis in mice.
http://www.pnas.org/content/110/45/E4213.abstract
320 Tumour-on-a-chip provides an optical window into nanoparticle tissue transport.
http://www.nature.com/ncomms/2013/131031/ncomms3718/full/ncomms3718.html
319 Bispecific small molecule–antibody conjugate targeting prostate cancer.
http://www.pnas.org/content/110/44/17796.abstract
318 Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans.
http://www.pnas.org/content/110/44/17945.abstract
317 Aging predisposes to acute inflammatory induced pathology after tumor immunotherapy.
http://jem.rupress.org/content/210/11/2223.abstract
316 Switch of glycolysis to gluconeogenesis by dexamethasone for treatment of hepatocarcinoma.
http://www.nature.com/ncomms/2013/131022/ncomms3508/full/ncomms3508.html
315 Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy.
http://www.nature.com/nbt/journal/v31/n10/full/nbt.2678.html
314 Mutational landscape and significance across 12 major cancer types.
http://www.nature.com/nature/journal/v502/n7471/full/nature12634.html
313 Magneto-electric Nanoparticles to Enable Field-controlled High-Specificity Drug Delivery to Eradicate Ovarian Cancer Cells.
http://www.nature.com/srep/2013/131016/srep02953/full/srep02953.html
312 Diagnostic leukapheresis enables reliable detection of circulating tumor cells of nonmetastatic cancer patients.
http://www.pnas.org/content/110/41/16580.abstract
311 Lipid-Coated Cisplatin Nanoparticles Induce Neighboring Effect and Exhibit Enhanced Anticancer Efficacy.
http://pubs.acs.org/doi/abs/10.1021/nn403606m
310 Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk.
http://www.nature.com/ng/journal/v45/n10/abs/ng.2733.html
309 The integrated landscape of driver genomic alterations in glioblastoma.
http://www.nature.com/ng/journal/v45/n10/abs/ng.2734.html
308 Emerging landscape of oncogenic signatures across human cancers.
http://www.nature.com/ng/journal/v45/n10/abs/ng.2762.html
307 Enabling transparent and collaborative computational analysis of 12 tumor types within The Cancer Genome Atlas.
http://www.nature.com/ng/journal/v45/n10/abs/ng.2761.html
306 The Cancer Genome Atlas Pan-Cancer analysis project.
http://www.nature.com/ng/journal/v45/n10/abs/ng.2764.html
|
